At the news
? NEUTRALIMPACT 6/10 8-K filed Apr 23, 2026 at 16:09 ET
Amicus Therapeutics announced that the French Ministry of Economics and Finance has granted foreign direct investment clearance for its acquisition by BioMarin Pharmaceutical. This satisfies the final regulatory condition, with the merger now expected to close on April 27, 2026.
- French Ministry of Economics and Finance granted foreign direct investment (FDI) clearance for the merger with BioMarin.
- This clearance satisfies the final regulatory condition to the merger.
- The merger is expected to close on April 27, 2026.
- The transaction was first announced on December 19, 2025.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access